Measuring technetium-99m-MAG3 clearance with an improved camera-based method. 1995

A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
Department of Radiology, Emory University School of Medicine, Atlanta, Georgia, USA.

Because commercially available camera-based methods are not optimized, they fail to account for dose infiltration, table attenuation and correspondence between time of injection and starting the camera. We have developed a more optimized technique to calculate camera-based clearances and applied this technique in the design of a camera-based clearance method for 99mTc-MAG3. METHODS Technetium-99m-MAG3 scintigraphy was performed in 20 patients who had varying degrees of renal function. Data were acquired posteriorly in supine patients at 2 sec/frame for 24 frames, 15 sec/frame for 16 frames and 30 sec/frame for 40 frames. Background correction was performed using an automated elliptical region of interest. Renal depth was estimated using improved regression equations and an empirically determined attenuation coefficient derived from phantom studies. Corrections were made for table attenuation and time discrepancies between dose injection and starting the camera. The percent injected dose in the kidney at 1-2, 1-2.5 and 2-3 min postinjection and the percent injected dose at those time periods corrected for body surface area were correlated with MAG3 clearance based on a single injection, two-compartment model. RESULTS There was high correlation between the percent injected dose in the kidney at all three time periods and the multisample clearance. Correcting for body surface areas significantly improved the correlation coefficients. Consequently, regression equations were developed to predict multisample clearance based on percent dose and body surface area. CONCLUSIONS The optimization features described in this method should improve precision when sequential studies are conducted in the same patient.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011866 Radioisotope Renography Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. Renography,Radioisotope Renographies,Renographies,Renographies, Radioisotope,Renography, Radioisotope
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017263 Technetium Tc 99m Mertiatide A technetium diagnostic aid used in renal function determination. 99mTc-MAG3,Tc 99m Mertiatide,Technetium-99m-MAG3,99mTc-Mercaptoacetyltriglycine,TechneScan MAG3,Technetium 99m Mercaptoacetylglycyl-glycyl-glycine,Technetium-99m-Mercaptoacetylglycylglycylglycine,Technetium-99m-Mercaptoacetyltriglycine,99m Mercaptoacetylglycyl-glycyl-glycine, Technetium,99m Mertiatide, Tc,99mTc MAG3,99mTc Mercaptoacetyltriglycine,MAG3, TechneScan,Mercaptoacetylglycyl-glycyl-glycine, Technetium 99m,Mertiatide, Tc 99m,Technetium 99m MAG3,Technetium 99m Mercaptoacetylglycyl glycyl glycine,Technetium 99m Mercaptoacetylglycylglycylglycine,Technetium 99m Mercaptoacetyltriglycine

Related Publications

A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
June 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
August 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
April 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
January 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
September 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
November 2011, Clinical nuclear medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
December 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
November 2021, Clinical physiology and functional imaging,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
January 1991, European journal of nuclear medicine,
A Taylor, and P L Corrigan, and J Galt, and E V Garcia, and R Folks, and M Jones, and A Manatunga, and D Eshima
November 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!